New formulation of sulindac for inhibiting angiogenesis and neo-lymphangiogenesis, and ophthalmic composition comprising the same
KR20130070830A
Prox 1 sirna inhibiting neo-lymphangiogenesis and ophthalmic composition comprising the same
KR20120009532A
Cationic lipid, method for manufacturing the same and delivery system comprising the same
WO2010056040A2
Novel erythropoietin conjugates bonded with a biocompatible polymer
KR20100102335A
Novel water-soluble betulin derivatives, a preparation thereof and a cosmetic composition comprising the same for improving wrinkles
KR100810034B1
- 105 siRNA of NF-kB p105 for inhibiting cell proliferation and migration and a composition comprising same
KR100829890B1
Novel retinol derivatives, process for the preparation thereof and cosmetic composition comprising the same for improving wrinkle
KR100825519B1
A chitosan based polymer conjugate and a method for producing the same
CN1767858A
Biologically active material conjugated with biocompatible polymer with 1:1 complex, preparation method thereof and pharmaceutical composition comprising the same
EP1608408A1
Biologically active material conjugated with biocompatible polymer with 1:1 complex, preparation method thereof and pharmaceutical composition comprising the same
EP1490402A1
Preparation of g-csf stoichiometrically conjugated with biocompatible polymers at cystein residue
WO03045436A1
Biologically active non-antigenic copolymer and conjugates thereof and methods for producing the same
